Form 4: Ekso Bionics Director Lathan Increases Stake in Company

Director Corinna Lathan has been actively purchasing Ekso Bionics Holdings, Inc. (EKSO) common stock, increasing her holdings through multiple transactions.

Summary

• Corinna Lathan, a director of Ekso Bionics Holdings, Inc., has reported several transactions involving the company's common stock.
• On August 10, 2023, Lathan purchased 4,201 shares at a price of $1.25 per share.
• On August 23, 2023, she acquired an additional 5,500 shares at $0.9494 per share.
• A further purchase of 4,032 shares was made on November 2, 2023, at $1.2412 per share.
• Following these transactions, Lathan's total direct holdings in Ekso Bionics common stock amount to 147,990 shares, which includes 67,392 unvested RSUs.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed as a positive sign, but the scale of the purchases is relatively small.

Positives

• A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored as an indicator of management's sentiment about the company's prospects, relative to the broader market and industry trends.

Stakeholder Impact

• Shareholders may view the director's stock purchases as a positive signal.

Key Dates

Keywords

EKSO, Ekso Bionics, Insider Trading, Form 4, Stock Purchase, Corinna Lathan, Director